NCT00645632: Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma |
|
|
| Completed | N/A | 60 | US | cisplatin, doxorubicin hydrochloride, ifosfamide, methotrexate, adjuvant therapy, neoadjuvant therapy, therapeutic conventional surgery | Mayo Clinic, National Cancer Institute (NCI) | Sarcoma | 01/95 | 01/08 | | |
NCT00673179: Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy |
|
|
| Terminated | N/A | 7 | US | Doxorubicin, AD, Hydroxydaunomycin hydrochloride, Cisplatin, Paraplatin®, Methotrexate, Leucovorin, Dexrazoxane, Zinecard, Ifosfamide, Ifex, Questionnaire, Survey, Gemcitabine, Gemzar, Gemcitabine Hydrochloride, Sargramostim, GM-CSF, Leukine™, Surgery, Mesna, Mesnex | M.D. Anderson Cancer Center | Osteosarcoma | 11/10 | 11/10 | | |
